Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmala Biotech Holdings Inc
C.MDMA
Alternate Symbol(s):
MDXXF
PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines...
: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:MDMA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Jun 20, 2024 8:30am
Buzz on the Bullboards: From innovating traffic enforcement to cancer breakthroughs
The past week on the TSX has been one for the books, with significant gains driven largely by advancements in the technology sector.
read article.
(5)
•••
Jimmycootes
X
View Profile
View Bullboard History
Post by
Jimmycootes
on Jun 13, 2024 3:55pm
Over 2.2 million
Over 2.2 million shares traded at an average 13.6 cents. Great day! Tomorrow should be nice.
(5)
•••
Jimmycootes
X
View Profile
View Bullboard History
Post by
Jimmycootes
on Jun 13, 2024 1:41pm
High of 15.5
On our way back to 20 cents. Business as usual...
(6)
•••
1991nightmaress
X
View Profile
View Bullboard History
Post by
1991nightmaress
on Jun 10, 2024 4:05pm
Great read
https://www.medicalgold.ca/featured/exclusive-interview-with-nick-kadysh-pharmalas-ceo-on-fda-adcomm-mdma-decision
(533)
•••
inviolablspirit
X
View Profile
View Bullboard History
Post by
inviolablspirit
on Jun 07, 2024 3:40pm
Junior Market needs better regulation
What a messed up junior market. Regardless of the sector nothing positive is moving stocks up and anything negative gets an overreaction. This only occurs when predatory short selling is
...more
(533)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Jun 07, 2024 9:54am
RE:Letter to shareholders
Nick's letter to the shareholders reiterates and confrims what I posted over the last few days. Pharmala's business has not changed with or without the panel's recommendation and in
...more
(6)
•••
1991nightmaress
X
View Profile
View Bullboard History
Post by
1991nightmaress
on Jun 07, 2024 9:22am
There you go
https://stockhouse.com/news/press-releases/2024/06/07/red-light-holland-announces-completion-of-full-psilocybin-extraction-report-with
(6)
•••
1991nightmaress
X
View Profile
View Bullboard History
Post by
1991nightmaress
on Jun 07, 2024 8:55am
All good
Long and strong
(35)
•••
polygraph46
X
View Profile
View Bullboard History
Comment by
polygraph46
on Jun 06, 2024 9:19pm
RE:Letter to shareholders
1991night: Thank you for posting the link to Nick's letter. For MDMA it's onwards and upwards. I like it...pg
(6)
•••
1991nightmaress
X
View Profile
View Bullboard History
Post by
1991nightmaress
on Jun 06, 2024 6:20pm
Letter to shareholders
https://pharmala.ca/media/2024/06/ceo-letter-to-shareholders?fbclid=IwZXh0bgNhZW0CMTAAAR2KuNQU8L5xCpGnKb3KRdl-B_pjp2NX1_zq9qMIQDmuk4_ucntrBJeGSVs_aem_AXV5I0RKDgDpqJ91O1TGsp
...more
(533)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Jun 06, 2024 11:12am
RE:Looking ahead
My expectation would be is that Nick and his team are out there secuing deals for more clincial trials in other countries. ...and looking for a partner for clinical testing of their MDMA variants (ex
...more
(533)
•••
inviolablspirit
X
View Profile
View Bullboard History
Post by
inviolablspirit
on Jun 06, 2024 10:31am
Looking ahead
As mentioned by Nick, his focus is places outside the US, so Pharmala will continue to truck ahead. Nothing has really changed for them. There are many drugs that are approved In Europe and
...more
(1)
•••
Firepoker1
X
View Profile
View Bullboard History
Comment by
Firepoker1
on Jun 06, 2024 8:15am
RE:RE:CSE the cesspool of trading
Pharmala has been known as a volitile stock for awhile...from the pump crew who took it up to .50''s. .. then short down to .08 area...it does not matter what Nick has accomplished, which has
...more
(533)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Jun 05, 2024 3:08pm
RE:CSE the cesspool of trading
It's a little mindboggling as to why Pharmala is taking the brunt of this pain today. Unless it is because they have the best way forward and the market sees an opportunity to take
...more
(208)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Jun 05, 2024 1:24pm
CSE the cesspool of trading
its not the stock or company its the criminal exchange and its traders
(533)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Jun 05, 2024 12:54pm
RE:RE:RE:Interesting trading today so far
Thanks! I did watch the entire review. I just find it odd to see such an overeaction to a recommendation from a panel that doesn't really have any direct effect on where Pharmala is
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
GameSquare Sells 25.5% Interest in FaZe Media for $9.5 Million